PRESTIGE-AF Stroke and Atrial Fibrillation Trial in Italy

PRESTIGE-AF Stroke and Atrial Fibrillation Trial in Italy

Professor Valeria Caso, stroke neurologist and former president of the European Stroke Organisation and Dr Fracesco Corea recently presented on the full operation of the clinical study with 15 participating centres in Italy.

This is part of the PRESTIGE-AF research project which is a European Union funded PRESTIGE-AF stroke research project to undertake a major clinical trial across Spain, Italy, France, the UK, Germany, and Austria. The trial is investigating recommended medication for stroke prevention in patients with atrial fibrillation.

The webinar is available here

Co-chair of the Life After Stroke webinar on 12 March announced

Co-chair of the Life After Stroke webinar on 12 March announced

We are delighted to introduce you to our new co-chair for the Life After Stroke Forum meeting on the 12 March 2021

Jurg Schwyter will be joining the opening webinar session, Life after stroke: priorities, challenges and ways forward, as co-chair. As a linguist, stroke survivor and aphasiac, Jurg wants to reach out about the impact of a stroke on language, communication and multilingualism.

Find out more about the session here: https://bit.ly/2NilTNl

Register for free here https://bit.ly/3cXlJFR

Programme for the 1st in our life after stroke series of webinars released

Programme for the 1st in our life after stroke series of webinars released

Life after stroke: priorities, challenges and ways forward on 12 March 2021 09.00-10.30 GMT

In this opening session we will hear from Bo Norrving (Sweden), Juliet Bouverie (UK), Liam Healy (Ireland) and Caterina Pistarini (Italy) on people’s experiences of the impact of stroke before and during the pandemic, and how healthcare and support services have adapted to meet the challenges of post-pandemic stroke care.

Register for FREE here

Click here for full programme

Programme for the 1st in our life after stroke series of webinars released

Launching Life After Stroke Series of Interactive Webinars for 2021 – Shining a spotlight on life after stroke

Today we are launching a series of free interactive events to build the life after stroke healthcare, research and patient community, stimulate debate and ultimately improve life after stroke care and build interest for SAFE’s 1st European Life After Stroke Forum on 11 March 2022. You can find out more information here

Register for our first webinar, Life After Stroke: Priorities, opportunities, and ways forward on 12 March 2021 10.00-11.30 CET here

Postponement of the 1st European Life After Stroke Forum 12 March 2021

Postponement of the 1st European Life After Stroke Forum 12 March 2021

The world has been transformed over the last year due to the pandemic and our healthcare systems have been put under tremendous strain.

SAFE has listened to the stroke clinical community in Europe and we have decided to postpone our full virtual conference planned for 12 March 2021 until 11 March 2022.

Life after stroke is a priority for SAFE and we’ll be continuing our life after stroke programme of activities during 2021 to demonstrate our commitment to make life meaningful after stroke.

We will be planning a series of events during 2021 that will focus on life after stroke, to build and strengthen our stroke community and ensure stroke survivors voice is heard.

Our first event on 12 March 2021, will be one of many events that will address the issues around life after stroke to build up interest, enthusiasm and momentum in advance of the full conference meeting in March 2022.

More details to follow shortly.

WHO launches updated clinical management guidance for COVID-19, including additional recommendation on stroke

WHO launches updated clinical management guidance for COVID-19, including additional recommendation on stroke

COVID-19 is associated with neurological manifestations, including stroke. In many cases, these have been reported even without respiratory symptoms. COVID-19 has been associated with acute cerebrovascular disease (including ischaemic and haemorrhagic stroke). 

Patients presenting with rapidly developing neurological symptoms suggestive of stroke should be evaluated as soon as possible and standard stroke protocols should be followed including systemic thrombolysis and/or intra-arterial thrombectomy, if indicated.  

Standard IPC measures must be followed during the clinical evaluation, neuroimaging or procedures for patients with stroke. The guidance also remarks that strokes can be missed in severely sick or unresponsive ICU patients and a low threshold for further evaluation (including neuroimaging) is recommended for acute neurological worsening. Read the full guidance here COVID-19 Clinical management: living guidance (who.int) 

Mechanical thrombectomy offers good value for money in Europe

Mechanical thrombectomy offers good value for money in Europe

A paper published this month in Stroke Journal shows that treating all eligible patients with mechanical thrombectomy generated health and social care costs of €11 billion compared with €12 billion for current practice. Ramon Luengo-Fernandez and his team at the Health Economics Research Centre, University of Oxford, undertook the research for SAFE and was originally published, in At What Cost, the Economic Impact of Stroke in Europe. Find out more safestroke.eu/economic-impact-of-stroke 

 

SHOT CALLERS: A Virtual Event on COVID-19 Vaccines

SHOT CALLERS: A Virtual Event on COVID-19 Vaccines

The European Patient Forum are hosting a event on all things related to the COVID-19 vaccines on Thursday, 28 January 2021 – 15:00-16:15 CET.

The COVID-19 pandemic has led to the development and approval of new vaccines in a much shorter time-frame than usual. As a result, there are still several questions that patients and civil society need to be answered.

Join them for a virtual event on 28 January 2021 between 15:00-16:15 CET with credible experts in the field of therapeutics and vaccines to shed light on all things related to the COVID-19 vaccines.

EPF Special Advisor Nicola Bedlington will moderate a lively and informative discussion with:

  • Prof. Jean-Michel Dogne, Member of WHO Global Advisory Committee on Vaccine Safety,
  • Prof. Guido Rasi, former Executive Director of European Medicines Agency (EMA) and;
  • Marco Greco, President of European Patients’ Forum.

A Q&A session will follow the live discussion.

Register: https://register.gotowebinar.com/register/1295587948611270156

Event Agenda

Participation is free so please share amongst your colleagues and networks.

We hope this event will bring greater knowledge and awareness and instil greater European confidence in vaccination